M&A Deal Summary

Stallergenes Greer Acquires Alergo Pharma S.R.L

On July 21, 2014, Stallergenes Greer acquired healthcare services company Alergo Pharma S.R.L

Acquisition Highlights
  • This is Stallergenes Greer’s 1st transaction in the Healthcare Services sector.
  • This is Stallergenes Greer’s 1st transaction in Argentina.

M&A Deal Summary
Date 2014-07-21
Target Alergo Pharma S.R.L
Sector Healthcare Services
Buyer(s) Stallergenes Greer
Deal Type Add-on Acquisition

Target

Alergo Pharma S.R.L

Balvanera, Argentina
Alergo Pharma S.R.L is a manufacturer of allergen immunotherapy drugs.

Search 192,800 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Stallergenes Greer

London, United Kingdom

website

Category Company
Sector Life Science
Revenue 251M EUR (2014)
DESCRIPTION

Stallergenes Greer is a global biopharmaceutical company specializing in the diagnosis and treatment of respiratory allergies through the development and commercialization of Allergy Immunotherapy products and services. The company's purpose is to enable precision medicine to improve life for people with allergies. Stallergenes Greer is headquartered in London.

DEAL STATS #
Overall 1 of 4
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 1 of 3
Country (Argentina) 1 of 1
Year (2014) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-08 GREER Laboratories

Lenoir, North Carolina, United States

GREER Laboratories, Inc. is a provider of allergenic extracts in the United States for the diagnosis and treatment of allergies in both humans and animals.

Buy -
Mergr

Product

Company

Legal